Akero Therapeutics Inc (AKRO) stock is higher by 56.98% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AKRO stock a score of 73 out of a possible 100.
That rank is primarily influenced by a fundamental score of 94. In addition to the average rating from Wall Street analysts, AKRO stock has a mean target price of 56.666. This means analysts expect the stock to climb 100.87% over the next 12 months. AKRO's rank also includes a short-term technical score of 83. The long-term technical score for AKRO is 42.
What's Happening with AKRO Stock Today
Akero Therapeutics Inc (AKRO) stock is up 0.07% while the S&P 500 is higher by 1.35% as of 1:05 PM on Wednesday, Oct 7. AKRO is higher by $0.02 from the previous closing price of $28.19 on volume of 206,418 shares. Over the past year the S&P 500 has risen 17.74% while AKRO is higher by 56.98%. AKRO lost -$2.09 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Akero Therapeutics Inc (AKRO) Stock.
